CINPHA: Cinclus Pharma Holding AB (publ) - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Cinclus Pharma Holding AB (publ)

SWE:CINPHA

SummaryFactSheetFinancial
Price
kr12.14
Loss Chance
54.1%
2.06JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Pharmaceuticals
8 / 14
Health Care
78 / 107
Sweden
?
527 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Camurus AB (publ)
SWE:CAMX
6.20
kr525.50
170.39%
Corline Biomedical AB
SWE:CLBIO
1.77
kr18.20
100.00%
Enzymatica AB (publ)
SWE:ENZY
2.86
kr2.43
100.00%
IRLAB Therapeutics AB (publ)
SWE:IRLAB A
0.71
kr1.26
100.00%
Karolinska Development AB (publ)
SWE:KDEV
2.46
kr2.39
100.00%
Jitta Factors
Growth Opportunity (22)
Recent Business Performance (56)
Financial Strength (30)
Return to Shareholders (0)
Competitive Advantage (31)
Jitta Signs
Recent IPOLess than 3 years
Operating MarginInconsistent
Recent Business PerformanceEarning decline 169.60% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.06
100.00%
2.16
102.25%
2.89
152.39%
Pharmaceuticals
6.20
170.39%
1.77
100.00%
2.86
100.00%
COMPANY DESCRIPTION
Cinclus Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China. The company’s lead product is linaprazan glurate, a potassium-competitive acid blocker that has completed Phase II clinical trial to treat gastroesophageal reflux disease. It also develops linaprazan glurate with antibiotics, which is in pre-clinical trial for the treatment of peptic ulcer bacteria Helicobacter pylori. Cinclus Pharma Holding AB (publ) was founded in 2014 and is headquartered in Stockholm, Sweden.
cincluspharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.